← Search & browse all drugs
ALIMENTARY TRACT AND METABOLISM › DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS › ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS › Synthetic anticholinergic agents in combination with psycholeptics
propantheline and psycholeptics
A03CA34
Forms & Strengths
- Propantheline bromide 15mg tablets
- Propantheline bromide 30mg tablets
- Propantheline bromide 15mg/5mL oral solution
Adult Dosing
- 15-30mg orally three to four times daily
- Maximum daily dose: 120mg
- Dose adjustment may be necessary for renal or hepatic impairment
Pediatric Dosing
- Safety and efficacy not established in pediatric patients
- Use with caution in pediatric patients, dose not established
Indications
- Treatment of peptic ulcer disease
- Gastroesophageal reflux disease (GERD)
- Irritable bowel syndrome (IBS)
- Gastroparesis
Mechanism of Action
- Competitive inhibition of acetylcholine at muscarinic receptors
- Reduces gastrointestinal motility and secretions
- Anticholinergic effects: decreased gastric acid secretion, decreased GI motility
Contraindications
- Myasthenia gravis
- Narrow-angle glaucoma
- Obstructive uropathy
- Obstructive diseases of the gastrointestinal tract
- Ulcerative colitis
Adverse Reactions
- Dry mouth, blurred vision, urinary retention
- Constipation, decreased sweating, orthostatic hypotension
- Tachycardia, palpitations, confusion, disorientation
- Nausea, vomiting, dizziness, headache
Drug Interactions
- Antihistamines: increased risk of anticholinergic side effects
- Opioid analgesics: increased risk of constipation and urinary retention
- Antidepressants (tricyclic): increased risk of anticholinergic side effects
- Nitrates: decreased absorption of nitrates
Curated Content: Needs Vetting Before Put to Clinical Use